MEDISIX THERAPEUTICS
Medisix Therapeutics is a Singapore-based immune engineering company developing novel cellular therapies to address T cell malignancies. Their technology platform originates from world expert in translational immunology, Professor Dario Campana, MD, PhD, a physician scientist who pioneered chimeric antigen receptor T cell (CAR-T) biology. Their programs utilize proprietary immune engineering approaches that enable T cell leukemias and lymphomas to be targeted with cell therapy.
MEDISIX THERAPEUTICS
Social Links:
Industry:
Biotechnology Chemical Engineering Life Science
Founded:
2018-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.medisixtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Rectify Pharmaceuticals
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Resolution Therapeutics
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Temasek Holdings
Temasek Holdings investment in Series A - Medisix Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series A - Medisix Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Medisix Therapeutics
Official Site Inspections
http://www.medisixtx.com
- Host name: jwhlaw.com
- IP address: 192.254.234.133
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Medisix Therapeutics"
Medisix – Leading the way in T-cell therapies
TRANSFORMING THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES MediSix Therapeutics is developing game-changing T-cell therapies by leveraging an array of …See details»
Medisix Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Medisix Therapeutics is a Singapore-based immune engineering company developing novel cellular therapies to address T cell malignancies. Their …See details»
about – Medisix
Unlike other cell therapy companies, we generate immune cells that lack specific surface molecules to enhance their anti-cancer activity. In addition to cancer, immune cells that target …See details»
Our vision and mission - medisixtx.com
3 2016 2017-2018 2019 and beyond 2019-2020 2021 and beyond Renowned expert in cell therapy and creator of the first anti-CD19-41BB-CD3z CAR, Professor DarioSee details»
MediSix Therapeutics - LinkedIn
MediSix Therapeutics | 1,008 followers on LinkedIn. We believe that T-cell therapies will radically change the treatment of cancer and autoimmune diseases. At MediSix, our mission is to develop ...See details»
Medisix Therapeutics - 2025 Company Profile - Tracxn
Mar 7, 2025 Medisix Therapeutics - Developer of CAR-T therapies to treat cancer and autoimmune diseases. Raised a total funding of $62.9M over 3 rounds from 3 investors. …See details»
MediSix Therapeutics Overview | SignalHire Company Profile
Organization Website: medisixtx.com : MediSix Therapeutics industries Biotech: Headquarters Location: 11 Biopolis Way, Helios, #05-08/09, Singapore, 138667 SG 11 Biopolis Way, Helios, …See details»
Medisix Therapeutics Pte Ltd. - SignalHire
Organization Website: medisixtx.com : Social Links: Medisix Therapeutics... industries Biotech, Biotechnology: Headquarters Location: 79 Ayer Rajah Cres, Singapore, 13 SG 79 Ayer Rajah …See details»
Medisix Therapeutics Pte Ltd. - Drug pipelines, Patents, Clinical ...
Www.medisixtx.com. Startups | Holding Company | 2018 | Singapore | 10-50 | www.medisixtx.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational …See details»
Medisix Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Medisix Therapeutics, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Medisix Therapeutics - Overview, News & Similar companies
Apr 15, 2021 Medisix Therapeutics contact info: Phone number: (617) 686-3640 Website: www.medisixtx.com What does Medisix Therapeutics do? Medisix Therapeutics is an Immune …See details»
Medisix Therapeutics - Craft
Medisix Therapeutics is an immune engineering company developing cellular therapies to address T cell malignancies. It utilizes proprietary immune engineering approaches that enable T cell …See details»
Contact – Medisix
Alicia joined MediSix as our Assoc. Director of Development, spearheading our Development team’s efforts to transition Discovery assets into clinical trials.See details»
MediSix Therapeutics Management Team | Org Chart
Medisixtx.com; View Similar People. Related Companies Zagro Singapore Pte Ltd. 81 $64.2m Cordlife Group Limited. 877 $40.8m Nitto Denko Asia Technical Centre. 27 $6.3b Trendlines …See details»
Medisix Therapeutics - Owler
Medisix Therapeutics’s Profile, Revenue and Employees. Medisix Therapeutics focuses on developing chimeric antigen receptor T cells for the treatment of lymphoma and leukemia. …See details»
MediSix Therapeutics Information - RocketReach
Medisixtx.com; View Similar People. Related Companies Zagro Singapore Pte Ltd. 82 $64.2m Cordlife Group Limited. 846 $40.8m Nitto Denko Asia Technical Centre. 26 $6.3b Trendlines …See details»
Medisix Therapeutics | CipherBio
Explore Medisix Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
MediSix Therapeutics - PitchBook
MediSix Therapeutics General Information Description. Developer of cellular therapies designed to address T-cell malignancies. The company's technology platform is based on genetic …See details»
Technology - Medisix
T-cell malignancies by engineering CAR T-cells lacking CD7, CD3, CD2 and/or other T-cell antigens; Other tumors by engineering CAR T-cells, TCR T-cells, TILs, or other immune cells …See details»
Twist Bioscience Signs Antibody Discovery Collaboration with …
[email protected] . Author: Anne Bowdidge Created Date: 20220329234213Z ...See details»